Ceftolozane/tazobactam versus colistin in the treatment of ventilator-associated pneumonia due to extensively drug-resistant Pseudomonas aeruginosa

Resistant strains of Pseudomonas aeruginosa are common pathogens in the intensive care unit (ICU), limiting available therapeutic options. We aimed to compare ceftolozane/tazobactam (C/T) with colistimethate sodium (CMS) in the treatment of ventilator-associated pneumonia (VAP) due to extensively dr...

Descripción completa

Detalles Bibliográficos
Autores principales: Mogyoródi, Bence, Csékó, András B., Hermann, Csaba, Gál, János, Iványi, Zsolt D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8924223/
https://www.ncbi.nlm.nih.gov/pubmed/35292686
http://dx.doi.org/10.1038/s41598-022-08307-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8924223/
https://www.ncbi.nlm.nih.gov/pubmed/35292686
http://dx.doi.org/10.1038/s41598-022-08307-9

Ejemplares similares